Generic Drug Review June 2017

The name change of the Generic Pharmaceutical Association to the Association for Accessible Medicines reflects a new identity that better represents the organization’s mission of making medications more accessible to individuals who need them.

Triptans, as combination therapy or monotherapy, are the first-line option for the treatment of migraine in adults aged 12 years and older.

Although these agents are effective acid suppressants, the use of PPIs is frequently debated based on reports of new potential adverse events.

A recent warning advises the avoidance of concomitant use of opiates and benzodiazepines, most of which are available as generics.

An awareness of recent drug approvals, which offer cost-effective treatment options, can help pharmacists facilitate care and improve overall outcomes.

Competition is the key cost driver, and the challenge is striking a balance between corporate profitability and the health needs of the public.